CONTEXT: Launch announcement for a patient-centric chronic pancreatitis registry, PACT-CP. The registry will be Us only and aims to assess unmet needs, therapeutic burden and the overall patient experience. IMPACT: Continue Reading
CONTEXT: Report of data presented at ASCO 2021 on cetuximab in metastatic colorectal cancer (mCRC) | US only data IMPACT: Low READ TIME: 2 mins Quality Level Mean [1 – Continue Reading
CONTEXT: Commercial announcement of a joint initiative between Hoffmann-La Roche and BC Cancer along with Canadian Personalised Healthcare Innovation Network (CPHIN) to create an RWE framework in British Columbia to Continue Reading
CONTEXT: Real-world study from Japan showing increased rates of pneumonitis with first-line pembrolizumab plus chemotherapy in patients with advanced NSCLC. IMPACT: Medium READ TIME: 2 mins Quality Level Mean [1 Continue Reading
CONTEXT: Oncology news article on use of RWR in oncology. Nothing new in terms of data use, more confirmation of RWD in oncology research. However, an interesting perspective from the Continue Reading
COMMENTS: Good story on use of RWE / RWR in oncology. READ TIME: 2 mins *1. “Sir Mick Peake, clinical director for the Centre for Cancer Outcomes within UCLH’s Cancer Continue Reading
Comments – Part of the EMA’s continued commitment to RWE in support of medicinal product utilisation. When you see regulators investing in infrastructure like this, you know they are serious Continue Reading
